Viewing Study NCT02945267


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-02-06 @ 8:19 AM
Study NCT ID: NCT02945267
Status: UNKNOWN
Last Update Posted: 2016-10-26
First Post: 2016-10-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module